Outsourcing Pharma
MAY 12, 2022
The two companies are forming a European Medical Advisory Committee to better connect patients and physicians, inviting other trial professionals to join in.
pharmaphorum
MAY 12, 2022
AbbVie’s would-be blockbuster Rinvoq has notched up another positive trial in Crohn’s disease, showing that it can achieve clinical remission over a full year when used as a maintenance therapy. The results of the U-ENDURE study bolster the clinical case for Rinvoq (upadacitinib), which is trying to become the first drug in the JAK inhibitor class to be approved by the FDA for Crohn’s disease with a filing due this year.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
MAY 12, 2022
The study is the UK’s most comprehensive allergy test, analysing 295 allergens, including well known potential food allergens
Outsourcing Pharma
MAY 12, 2022
Leaders from the biotech company share advice on how such organizations can make the most of often limited resources via smart strategy and collaboration.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
MAY 12, 2022
German drugmaker Boehringer Ingelheim has sold an artificial intelligence-powered software platform it developed to monitor drug safety data to ArisGlobal, which provides cloud software to life sciences companies. The platform – called BRASS (Benefit-Risk Analytic System) – was developed by Boehringer to unlock hidden patient safety signals from large data sets, and will be layered into ArisGlobal’s LifeSphere safety and pharmacovigilance platform.
Pharma Times
MAY 12, 2022
High street service has been launched to support those experiencing symptoms potentially connected to the menopause
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
MAY 12, 2022
Johnson & Johnson has appointed Thibaut Mongon as the chief executive of its consumer health division, which is scheduled to be spun off into a listed company by the end of 2023. J&J announced its intention to separate consumer health from its faster-growing prescription medicine and medical device businesses last November, creating a separate company that will be home to well-recognised brands, including Band-Aid dressings, Johnson’s baby range, Listerine mouthwash, and Tylenol pa
pharmaphorum
MAY 12, 2022
AbbVie’s Allergan subsidiary and Teva are reportedly considering making a $5 billion-plus offer to try to bring opioid liability lawsuits to a conclusion. According to a Bloomberg report , the two drugmakers are facing more than 3,500 lawsuits related to their role in fuelling the opioid crisis in the US, and have been in talks over a possible settlement for more than a year.
pharmaphorum
MAY 12, 2022
People who trust pharma are more interested in using the industry’s services – making building confidence in the sector key to realising the potential of patient centricity. Just 13% of people completely trust the pharma companies they interact with, 68% say the interactions feel transactional, and only a third agree that organisations know their communication preferences.
Expert insights. Personalized for you.
95 
Let's personalize your content